6-Month Antibody Response to COVID-19 Vaccines Remains Similar in Patients With Solid Tumors Vs General Population

Six months after receiving a second dose of the Pfizer-BioNTech COVID-19 vaccine, patients with solid tumors retained similar levels of COVID-19 antibodies in their blood as individuals without cancer.

Read the full article here

Related Articles